Pereira C M, Nosbisch C, Baughman W L, Unadkat J D
Department of Pharmaceutics, BG-20, University of Washington, Seattle 98195, USA.
Antimicrob Agents Chemother. 1995 Feb;39(2):343-5. doi: 10.1128/AAC.39.2.343.
Since zidovudine and ddI may be used in combination in the future to treat pregnant women who are human immunodeficiency virus positive, we conducted a study to determine whether zidovudine affects the transfer of ddI across the placenta. Zidovudine and ddI were infused simultaneously to three near-term pregnant macaques (Macaca nemestrina) at 156 +/- 1.5 days of gestation. Samples of maternal and fetal blood and amniotic fluid were drawn at intervals for 30 h. The steady-state dideoxyinosine concentrations in the plasma of the dam (Cssd), the fetus (Cssf), and the amniotic fluid (Cssa) and the ratios Cssf/Cssd and Cssa/Cssf were found to be not significantly different from the values previously determined after the administration of ddI alone during the same pregnancy. We conclude that concurrent zidovudine administration does not affect the transfer of ddI across the placenta in near-term Macaca nemestrina.
鉴于齐多夫定和去羟肌苷未来可能联合用于治疗人类免疫缺陷病毒呈阳性的孕妇,我们开展了一项研究,以确定齐多夫定是否会影响去羟肌苷穿过胎盘的转运。在妊娠156±1.5天时,将齐多夫定和去羟肌苷同时输注给三只近足月怀孕的猕猴(食蟹猴)。在30小时内定期采集母体和胎儿血液以及羊水样本。发现母猴血浆(Cssd)、胎儿血浆(Cssf)和羊水中去羟肌苷的稳态浓度(Cssa)以及Cssf/Cssd和Cssa/Cssf的比值与先前在同一孕期单独给予去羟肌苷后测定的值无显著差异。我们得出结论,同时给予齐多夫定不会影响去羟肌苷在近足月食蟹猴中穿过胎盘的转运。